Neuroprotection by the stable nitroxide 3-carbamoyl-proxyl during reperfusion in a rat model of transient focal ischemia

Journal of Neurosurgery

Volumn 98, Issue 2, 2003, Pages 393-396

  Hu, Guohan ^a   Lyeth, Bruce G ^a   Zhao, Xueren ^a   Mitchell, James B ^a   Watson, Joe C ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3 carbamoyl proxyl; Cerebral ischemia; Nitroxide; Rat; Reperfusion damage

Indexed keywords

3 CARBAMOYL 2,2,5,5 TETRAMETHYLPYRROLIDINE 1 OXYL; NITROXIDE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; MALE; MIDDLE CEREBRAL ARTERY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 0037306010     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.98.2.0393     Document Type: Article

References (27)

1. Albers GW, Goldstein LB, Hall D, et al: Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. JAMA 286:2673-2682, 2001
2. Clark WM, Wechsler LR, Sabounjian LA, et al: A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology 57:1595-1602, 2001
3. Committee TIS: Tirilazad mesylate in acute ischemic stroke: a systematic review. Tirilazad International Steering Committee. Stroke 31:2257-2265, 2000
4. Cuscela D, Coffin D, Lupton GP, et al: Protection from radiation-induced alopecia with topical application of nitroxides: fractionated studies. Cancer J Sci Am 2:273, 1996
5. Davis SM, Lees KR, Albers GW, et al: Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist. Stroke 31:347-354, 2000
6. Demirkaya S, Topcuoglu MA, Aydin A, et al: Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia. Eur J Neurol 8:43-51, 2001
7. Gelvan D, Saltman P, Powell SR: Cardiac reperfusion damage prevented by a nitroxide free radical. Proc Natl Acad Sci USA 88:4680-4684, 1991
8. Hahn SM, DeLuca AM, Coffin D, et al: In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides. Int J Radiat Oncol Biol Phys 42:839-842, 1998
9. Hahn SM, Sullivan FJ, DeLuca AM, et al: Hemodynamic effect of the nitroxide superoxide dismutase mimics. Free Radic Biol Med 27:529-535, 1999
10. Krishna MC, DeGraff W, Hankovszky OH, et al: Studies of structure-activity relationship of nitroxide free radicals and their precursors as modifiers against oxidative damage. J Med Chem 41:3477-3492, 1998
11. Krishna MC, Samuni A, Taira J, et al: Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism. J Biol Chem 271:26018-26025, 1996
12. Lees KR, Lavelle JF, Cunha L, et al: Glycine antagonist (GV150526) in acute stroke: a multicentre, double-blind placebo-controlled phase II trial. Cerebrovasc Dis 11:20-29, 2001
13. Marshall JW, Duffm KJ, Green AR, et al: NXY-059, a free radical - trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species. Stroke 32:190-198, 2001
14. Mason RB, Pluta RM, Walbridge S, et al: Production of reactive oxygen species after reperfusion in vitro and in vivo: protective effect of nitric oxide. J Neurosurg 93:99-107, 2000
15. Michel RP, Cruz-Orive LM: Application of the Cavalieri principle and vertical sections method to lung: estimation of volume and pleural surface area. J Microsc 150:117-136, 1988
16. Mitchell JB, DeGraff W, Kaufman D, et al: Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol. Arch Biochem Biophys 289:62-70, 1991
17. Mitchell JB, Krishna MC: Nitroxides as radiation protectors. Mil Med 167:49-50, 2002
18. Mitchell JB, Russo A, Kuppusamy P, et al: Radiation, radicals, and images. Ann N Y Acad Sci 899:28-43, 2000
19. Mitchell JB, Samuni A, Krishna MC, et al: Biologically active metal-independent superoxide dismutase mimics. Biochemistry 29:2802-2807, 1990
20. Morris GF, Bullock R, Marshall SB, et al: Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators. J Neurosurg 91:737-743, 1999
21. Muir KW, Holzapfel L, Lees KR: Phase II clinical trial of sipatrigine (619C89) by continuous infusion in acute stroke. Cerebrovasc Dis 10:431-436, 2000
22. Offer T, Mohsen M, Samuni A: An SOD-mimicry mechanism underlies the role of nitroxides in protecting papain from oxidative inactivation. Free Radic Biol Med 25:832-838, 1998
23. Pluta RM, Rak R, Wink DA, et al: Effects of nitric oxide on reactive oxygen species production and infarction size after brain reperfusion injury. Neurosurgery 48:884-893, 2001
24. Rak R, Chao DL, Pluta RM, et al: Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia. J Neurosurg 92:646-651, 2000
25. Samuni A, Krishna CM, Riesz P, et al: A novel metal-free low molecular weight superoxide dismutase mimic. J Biol Chem 263:17921-17924, 1988
26. Samuni A, Mitchell JB, DeGraff W, et al: Nitroxide SOD-mimics: modes of action. Free Radic Res Commun 12/13:187-194, 1991
27. Spranger M, Krempien S, Schwab S, et al: Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury. Correlation with clinical course and infarct size. Stroke 28:2425-2428, 1997